Alembic Pharmaceuticals informs about press release

02 Aug 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Nelarabine Injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial). It has enclosed press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

763.50 -3.65 (-0.48%)
20-Feb-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1285.45
Cipla 1337.50
Zydus Lifesciences 900.20
Lupin 2218.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×